Endogenous erythropoietin (EPO) levels were also inadequate to the degree of anemia and the patient was treated with steroids and recombinant EPO epoetin alpha 40,000 UI/week and vitamin supplementation with progressive increase of reticulocytes and transfusion independence. The gene discussed is EPO; the disease is anemia (phenotype).